Brain abnormalities in bipolar disorder detected by quantitative T1ρ mapping

Molecular Psychiatry

Volumn 20, Issue 2, 2015, Pages 201-206

  Johnson, C P ^a   Follmer, R L ^a   Oguz, I ^b   Warren, L A ^a   Christensen, G E ^b   Fiedorowicz, J G ^a,c   Magnotta, V A ^a   Wemmie, J A ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b University of Iowa   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BIPOLAR I DISORDER; BRAIN DISEASE; BRAIN MAPPING; CELL DENSITY; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER; BIPOLAR DISORDER; BRAIN; IMAGE PROCESSING; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT;

ADULT; AGED; BIPOLAR DISORDER; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84938551261     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.157     Document Type: Article

References (60)

1. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005; 10: 900-919.
2. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2000; 2: 180-190.
3. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006; 11: 663-679.
4. Kato T. Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 2007; 21: 1-11.
5. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29: 311-324.
6. Kato T, Murashita J, Kamiya A, Shioiri T, Kato N, Inubushi T. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity. Eur Arch Psychiatry Clin Neurosci 1998; 248: 301-306.
7. Beyer JL, Young R, Kuchibhatla M, Krishnan KR. Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review. Int Rev Psychiatry 2009; 21: 394-409.
8. Gunde E, Blagdon R, Hajek T. White matter hyperintensities: from medical comorbidities to bipolar disorders and back. Ann Med 2011; 43: 571-580.
9. Heng S, Song AW, Sim K. White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. J Neural Transm 2010; 117: 639-654.
10. Emsell L, Langan C, Van Hecke W, Barker GJ, Leemans A, Sunaert S et al. White matter differences in euthymic bipolar I disorder: a combined magnetic resonance imaging and diffusion tensor imaging voxel-based study. Bipolar Disord 2013; 15: 365-376.
11. Stertz L, Magalhaes PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 2013; 26: 19-26.
12. Kim S, Webster MJ. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2010; 15: 326-336.
13. Konradi C, Sillivan SE, Clay HB. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2012; 45: 37-47.
14. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
15. Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM. Neuroprogression in bipolar disorder. Bipolar Disord 2012; 14: 356-374.
16. Oz G, Alger JR, Barker PB, Bartha R, Bizzi A, Boesch C et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014; 270: 658-679.
17. Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000; 41: 661-681.
18. Sepponen RE, Pohjonen JA, Sipponen JT, Tanttu JI. A method for T1rho imaging. J Comput Assist Tomogr 1985; 9: 1007-1011.
19. Jin T, Autio J, Obata T, Kim SG. Spin-locking versus chemical exchange saturation transfer MRI for investigating chemical exchange process between water and labile metabolite protons. Magn Reson Med 2011; 65: 1448-1460.
20. Kettunen MI, Grohn OH, Silvennoinen MJ, Penttonen M, Kauppinen RA. Effects of intracellular pH, blood, and tissue oxygen tension on T1rho relaxation in rat brain. Magn Reson Med 2002; 48: 470-477.
21. Michaeli S, Burns TC, Kudishevich E, Harel N, Hanson T, Sorce DJ et al. Detection of neuronal loss using T1rho MRI assessment of 1H2O spin dynamics in the aphakia mouse. J Neurosci Methods 2009; 177: 160-167.
22. Magnotta VA, Heo HY, Dlouhy BJ, Dahdaleh NS, Follmer RL, Thedens DR et al. Detecting activity-evoked pH changes in human brain. Proc Natl Acad Sci USA 2012; 109: 8270-8273.
23. Jin T, Kim SG. Characterization of non-hemodynamic functional signal measured by spin-lock fMRI. Neuroimage 2013; 78: 385-395.
24. Jin T, Mehrens H, Hendrich KS, Kim SG. Mapping brain glucose uptake with chemical exchange-sensitive spin-lock magnetic resonance imaging. J Cereb Blood Flow Metab 2014; 34: 1402-1410.
25. Charagundla SR, Borthakur A, Leigh JS, Reddy R. Artifacts in T1rho-weighted imaging: correction with a self-compensating spin-locking pulse. J Magn Reson 2003; 162: 113-121.
26. Pierson R, Johnson H, Harris G, Keefe H, Paulsen JS, Andreasen NC et al. Fully automated analysis using BRAINS: AutoWorkup. Neuroimage 2011; 54: 328-336.
27. Halle M, Talos I-F, Jakab M, Makris N, Meier D, Wald L et al. Multi-modality MRIbased atlas of the brain. SPL: Boston, MA, 2013; URL: http://www.spl.harvard.edu/publications/item/view/2037.
28. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 2011; 54: 2033-2044.
29. Mori S, Oishi K, Jiang H, Jiang L, Li X, Akhter K et al. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 2008; 40: 570-582.
30. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29: 162-173.
31. Watts R, Andrews T, Hipko S, Gonyea JV, Filippi CG. In vivo whole-brain T1-rho mapping across adulthood: normative values and age dependence. J Magn Reson Imaging 2014; 40: 376-382.
32. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria, 2013; URL: http://www.R-project.org/.
33. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt F et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 2011; 45: 156-161.
34. Brambilla P, Bellani M, Yeh PH, Soares JC, Tansella M. White matter connectivity in bipolar disorder. Int Rev Psychiatry 2009; 21: 380-386.
35. Emsell L, McDonald C. The structural neuroimaging of bipolar disorder. Int Rev Psychiatry 2009; 21: 297-313.
36. Marlinge E, Bellivier F, Houenou J. White matter alterations in bipolar disorder: potential for drug discovery and development. Bipolar Disord 2014; 16: 97-112.
37. Langan C, McDonald C. Neurobiological trait abnormalities in bipolar disorder. Mol Psychiatry 2009; 14: 833-846.
38. Hamakawa H, Murashita J, Yamada N, Inubushi T, Kato N, Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci 2004; 58: 82-88.
39. Hosokawa T, Momose T, Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 243-250.
40. Altamura AC, Bertoldo A, Marotta G, Paoli RA, Caletti E, Dragogna F et al. White matter metabolism differentiates schizophrenia and bipolar disorder: a preliminary PET study. Psychiatry Res 2013; 214: 410-414.
41. Andreasen NC, Pierson R. The role of the cerebellum in schizophrenia. Biol Psychiatry 2008; 64: 81-88.
42. Hoppenbrouwers SS, Schutter DJ, Fitzgerald PB, Chen R, Daskalakis ZJ. The role of the cerebellum in the pathophysiology and treatment of neuropsychiatric disorders: a review. Brain Res Rev 2008; 59: 185-200.
43. Kim D, Cho HB, Dager SR, Yurgelun-Todd DA, Yoon S, Lee JH et al. Posterior cerebellar vermal deficits in bipolar disorder. J Affect Disord 2013; 150: 499-506.
44. Loeber RT, Sherwood AR, Renshaw PF, Cohen BM, Yurgelun-Todd DA. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophr Res 1999; 37: 81-89.
45. Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA. Cerebellar blood volume in bipolar patients correlates with medication. Biol Psychiatry 2002; 51: 370-376.
46. Bolbecker AR, Mehta C, Johannesen JK, Edwards CR, O'Donnell BF, Shekhar A et al. Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction. Bipolar Disord 2009; 11: 19-32.
47. Bolbecker AR, Hong SL, Kent JS, Forsyth JK, Klaunig MJ, Lazar EK et al. Paced finger-tapping abnormalities in bipolar disorder indicate timing dysfunction. Bipolar Disord 2011; 13: 99-110.
48. Bolbecker AR, Hong SL, Kent JS, Klaunig MJ, O'Donnell BF, Hetrick WP. Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. PLoS One 2011; 6: e19824.
49. Kohno T, Shiga T, Toyomaki A, Kusumi I, Matsuyama T, Inoue T et al. Effects of lithium on brain glucose metabolism in healthy men. J Clin Psychopharmacol 2007; 27: 698-702.
50. Forlenza OV, Coutinho AM, Aprahamian I, Prando S, Mendes LL, Diniz BS et al. Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [18F]FDG-PET study. ACS Chem Neurosci e-pub ahead of print 29 April 2014. doi:2010.1021/cn5000315.
51. Can A, Schulze TG, Gould TD. Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol Biochem Behav 2014; 123: 3-16.
52. Deoni SC. Quantitative relaxometry of the brain. Top Magn Reson Imaging 2010; 21: 101-113.
53. Mangia S, Liimatainen T, Garwood M, Michaeli S. Rotating frame relaxation during adiabatic pulses vs conventional spin lock: simulations and experimental results at 4 T. Magn Reson Imaging 2009; 27: 1074-1087.
54. Borthakur A, Wheaton AJ, Gougoutas AJ, Akella SV, Regatte RR, Charagundla SR et al. In vivo measurement of T1rho dispersion in the human brain at 1.5 tesla. J Magn Reson Imaging 2004; 19: 403-409.
55. Agarwal N, Port JD, Bazzocchi M, Renshaw PF. Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology 2010; 255: 23-41.
56. Witschey WR 2nd, Borthakur A, Elliott MA, Mellon E, Niyogi S, Wallman DJ et al. Artifacts in T1rho-weighted imaging: compensation for B1 and B0 field imperfections. J Magn Reson 2007; 186: 75-85.
57. Chen W, Takahashi A, Han E. Quantitative T1rho imaging using phase cycling for B0 and B1 field inhomogeneity compensation. Magn Reson Imaging 2011; 29: 608-619.
58. Li X, Han ET, Busse RF, Majumdar S. In vivo T1rho mapping in cartilage using 3D magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots (3D MAPSS). Magn Reson Med 2008; 59: 298-307.
59. Johnson CP, Thedens DR, Magnotta VA. Precision-guided sampling schedules for efficient T1rho mapping. J Magn Reson Imaging e-pub ahead of print 29 January 2014. doi:2010.1002/jmri.24518.
60. Johnson CP, Follmer RL, Oguz I, Warren LA, Christensen GE, Fiedorowicz JG et al. Quantitative T1rho mapping of bipolar disorder: basal differences in euthymia. Proc 22nd Annual Meeting Intl Soc Magn Reson Med 2014; 1: 835.